Article List

WPRIM Management System> DCMS> Journal of Breast Disease> 2016> 4> 2

Volume: 4 Issue: 2

1. Evaluation of Prognostic Factors and Validation of Tumor Response Ratios after Neoadjuvant Chemotherapy in Patients with Breast Cancer.	Page:108—115
2. Oncologic Effect of Oral Fluorouracil in Hormone Receptor-Negative T1a Node-Negative Breast Cancer Patients.	Page:116—121
3. Effects of Less than 60 Days Delay in Surgery on Tumor Progression and Survival Outcomes in Invasive Breast Cancer Patients.	Page:100—107
4. Prediction of Axillary Nodal Status according to the Axillary Lymph Node to Primary Breast Tumor Maximum Standardized Uptake Value Ratio on 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.	Page:92—99
5. Preoperative Breast Magnetic Resonance Imaging for the Assessment of the Size of Ductal Carcinoma In Situ.	Page:77—84
6. Analysis of the Relationship between Body Mass Index and Breast Cancer Incidence in Korean Women.	Page:64—69
7. Distress and Quality of Life for Breast Cancer Survivors during Follow-Up Periods in Korea.	Page:58—63
8. The Molecular Subtype Dependent Effect of Concurrent Radiotherapy and Systemic Therapy on Breast Cancer: Analysis of a Human In Vivo Model of Metastatic Brain Lesions.	Page:85—91
9. Reliability of Core Needle Biopsy in Evaluating Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2, and Ki-67 Status.	Page:70—76
10. Comparison of Prognosis according to Tumor Size in Small Breast Cancer with Lymph Node Involvement.	Page:48—57
11. Predictive Factors of Residual Metastatic Axillary Lymph Nodes after Neoadjuvant Chemotherapy in Node-Positive Breast Cancer.	Page:42—47
12. Selective B-RAF V600E Inhibitor PLX4032 Inhibits the Growth of Breast Cancer Cell Lines through Cell Cycle Arrest.	Page:33—41